�ٺ���Ƶ

News from �ٺ���Ƶ Health

NYU Opens Primary Care Walk-In Clinics To Pick Up Patients Without A Doctor. (Crain's New York Business)

Paywalled* (9/4) �ٺ���Ƶ Health has opened two primary care walk-in clinics in Manhattan, located at 540 Hudson St. in the West Village and 1465 Third Ave. on the Upper East Side, designed to treat common medical ailments and integrate patients without established doctors into its network of over 4,000 physicians, according to Andrew Rubin, senior vice president for clinical affairs and ambulatory care. The clinics feature four exam rooms and X-ray capabilities, and aim to expand �ٺ���Ƶ Health’s outpatient footprint.

The (9/4) The new “Care on Demand’ program provides a new and appointment-free way for New Yorkers to ‘procure the full spectrum of top-ranked clinical specialists available at one of our more than 300 locations,” Robert I. Grossman, MD, dean and CEO, said. Andrew W. Brotman, MD, executive vice president and vice dean for clinical affairs and strategy, and chief clinical officer, said that the concept “offers not only convenient care, but continuity of care all across our entire network.”

Also providing coverage is (9/4) newsletter brief.

�ٺ���Ƶ Health Resource Fair Raises Over $125,000 To Distribute Over 2,800 Backpacks Of School Supplies. (NY1-TV New York)

(9/3) In Brooklyn, a resource fair by the Family Health Centers at �ٺ���Ƶ Health raised over $125,000 to distribute and fund more than 2,800 backpacks filled with school supplies, while also offering health screenings; Larry K. McReynolds, clinical associate professor, Department of Population Health, Family Health Centers, executive director, said, “It makes me feel wonderful because I get to see that moms have that stress relieved.”

A ‘Tie-Breaker’ Study Of Abbott’s Heart Clip Brings More Questions Than Answers. (STAT)

Paywalled* (8/31)* Results from the RESHAPE-HF 2 trial, presented at the European Society of Cardiology meeting and published in the New England Journal of Medicine, revealed that Abbott’s MitraClip device improved health status and reduced hospitalizations due to heart failure but did not lower mortality rates, leading to ongoing debate among cardiologists about its efficacy for patients with less severe mitral regurgitation; Sunil Rao, MD, professor, Department of Medicine, the Leon H. Charney Division of Cardiology, commented, “How much are we willing to wait before a device gets approved while we’re dealing with this patient population that is struggling?”

The Wellness Industry: Financially Toxic, Says Ethicist. (Medscape)

Paywalled* (9/3)* Arthur L. Caplan, PhD, the Drs. William F. and Virginia Connolly Mitty Professor, Department of Population Health, Division of Medical Ethics, criticized the wellness industry for driving up healthcare costs without providing evidence of efficacy, stating, “Wellness interventions, whether it’s transcranial magnetism or all manner of supplements that are sold in health food stores, over and over again, we see a world in which wellness is promoted but no data are introduced to show that any of it helps, works, or does anybody any good.”

Vutrisiran Reduces Death, CV Events in ATTR Amyloidosis With Cardiomyopathy. (Healio)

(8/30) Reacting to a report that Alnylam Pharmaceuticals’ drug Amvuttra reduced cardiovascular risk by 28% in a Phase 3 trial, HELIOS-B, Jose A. Alvarez-Cardona, MD, assistant professor, Department of Medicine, the Leon H. Charney Division of Cardiology, wrote, “The results of this study highlight the importance of early diagnosis and initiating treatment as soon as possible. There was a significant reduction in all-cause mortality and CV events with vutrisiran, regardless of the baseline use of tafamidis.”

Also reporting is (8/30).

False-Positive Mammogram Results Discourage Future Screenings. (TODAY)

(9/3) Natalie E. Azar, MD, clinical associate professor, Department of Medicine, Division of Rheumatology, discusses the findings of researchers in a new study on mammograms, which found that false-positive results could affect a woman’s likelihood to return for future screenings and prevent successful detection of cancer.

Also reporting is (9/3).

Risk Of Death Among Individuals Who Donate Kidney At All-Time Low, Reveals JAMA Study. (Medical Dialogues (IND))

(9/3) Analyzing three decades of medical records representing 164,593 kidney donors nationwide, a team led by researchers at �ٺ���Ƶ Health found that by 2022, fewer than one death occurred for every 10,000 donations, translating to 36 deaths in total over 30 years. “While we had always understood that kidney donation is safe, our findings suggest that mortality among donors is extremely rare, and the procedure is safer than ever before,” said Allan Massie, PhD, director of the Center for Surgical and Transplant Applied Research (C-STAR) Quantitative Core at NYU Grossman School of Medicine. “These results demonstrate that the current guidelines used to inform potential kidney donors of their risks need to be updated to reflect nearly a decade of safety improvements,” said Dorry L. Segev, MD, PhD, professor, Department of Surgery, Division of Transplant Surgery, professor, Department of Population Health, vice chair for research, Department of Surgery and the Surgical Sciences. “As a kidney donor and research scientist in the field, it is reassuring to see the progress we have made,” said Macey L. Levan, JD, PhD, associate professor, Department of Surgery, Division of Transplant Surgery, and Department of Population Health.

How Hearing And Vision Loss Increase The Risk Of Dementia. (San Diego Union-Tribune)

The (9/3) Adults older than 65 who experience vision loss have a nearly 50 percent increased risk of developing dementia, but correcting those vision problems significantly reduces that risk, according to a report by an international commission on dementia prevention, which now includes vision impairment among its 14 modifiable risk factors for dementia; hearing aids also appear to reduce the chance of developing dementia, and James Russell Pike, MBA, research scientist, who collaborated on the study, said, “You’re not seeing an improvement, per se, but you’re seeing a reduction of decline.”

We Tested More Than A Dozen Popular Fitness Trackers – Our Favorite Is Less Than $200. (Women's Health)

(9/3) N’Namdi Nelson, CSCS, exercise physiologist, Sports Performance Center, recommends fitness trackers to patients for their accuracy in obtaining baseline measures, and he appreciates features like sleep tracking and hydration reminders, stating, “It can remind you to drink more water, which is essential to performance and assists in normalizing blood pressure.”

10 Hospitals In New York State Recognized As Best In America, 3 In Hudson Valley. (WNBF-AM Binghamton (NY))

Binghamton, NY (9/3) The Centers for Medicare and Medicaid Services awarded a five-star rating to 381 hospitals nationwide, including 10 in New York State, one of which is �ٺ���Ƶ Health.

What Is EEE, The Mosquito-Borne Disease That Killed A New Hampshire Man? (Fox News)

(9/3) “Fatigue and lethargy in the setting of infection can be a sign of pneumonia and potential sepsis, even without overt pulmonary symptoms,” Marc K. Siegel, MD, clinical professor, Department of Medicine, Division of General Internal Medicine and Clinical Innovation, told Fox News Digital.

In a separate embedded video, (9/3) “Marc K. Siegel, MD, clinical professor, Department of Medicine, Division of General Internal Medicine and Clinical Innovation discusses Eli Lilly’s response to the prescription drug craze on The Claman Countdown.’”

�ٺ���Ƶ Health Physician Discusses Report About Heavy Metals Found In Tampons. (WPTA-TV Fort Wayne (IN))

(9/3) A study discovered that some tampons might contain toxic metals like arsenic, lead, and cadmium, raising concerns about their safety for regular use; Sasha Hernandez, MD, clinical assistant professor, Departments of Population Health, and Obstetrics and Gynecology pointed out, “The vagina tissue is different from other tissue and it’s more absorptive but this study did not look at absorption rates.”

News from �ٺ���Ƶ Hospital—Long Island

�ٺ���Ƶ Conducting New COVID-19 Vaccine Trial. (Washington Square (NY) News)

The (9/3) �ٺ���Ƶ Health is one of three hospitals conducting a clinical trial as part of Project NextGen for a new COVID-19 vaccine designed by the National Institute of Allergy and Infectious Diseases, which is administered nasally to improve protection against mild infections and new variants; Martin Bäcker, MD, clinical assistant professor, Department of Medicine, Division of Infectious Diseases and Immunology, �ٺ���Ƶ Hospital—Long Island, leads the trial, stating, “the vaccine is administered via the nostrils to deliver its ‘message’ directly to the respiratory system, rather than to the arm muscles as current COVID-19 vaccines do.”